CMT Type 4 – CMT4 is caused when both versions of an important gene required for healthy myelin (SH3TC2) are deficient. To restore function of these genes, the gene therapy approach for CMT1X is also being tried for CMT4C by Dr. Kleopa. If successful, these studies may highlight a novel approach that will be applicable to other forms of CMT4.